The localization of tissue factor and apolipoprotein(a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition

Pathology Research and Practice

Volumn 192, Issue 3, 1996, Pages 224-232

  Ichikawa, K ^a   Nakagawa, K ^a   Hirano, K ^a   Sueishi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Apolipoprotein(a); Atherosclerosis; Fibrin; Fibrinogen; Tissue factor

Indexed keywords

APOLIPOPROTEIN A; FIBRIN; FIBRINOGEN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; FEMALE; FIBRIN FORMATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; STROMA; THORACIC AORTA; THROMBUS;

EID: 0029988783     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80225-1     Document Type: Article

References (48)

1. Archipoff G, Beretz A, Freyssinet JM, Klein-Soyer G, Brisson C, Cazenave JP (1991) Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem J 273; 679-684
2. Bajaj SP, Rapaport SI, Brown SF (1981) Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem 256: 253-259
3. Bartha K, Brisson C, Archipoff G, Salle C, Lanza F, Cazenave JP, Berets A (1993) Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saprienous vein endothelial cells by distinct mechanisms. J Biol Chem 268: 421-429
4. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium; characterization and comparison with the action of interleukin 1. Proc Natl Acad Sci USA 83: 4533-4537
5. Berg K, Dahlen G, Frick MH (1974) Lp(a) lipoprotein and prebeta1-lipoproteins in patients with coronary heart disease. J Clin Genet 6: 230-235
6. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr (1984) Interleukin-1 (IL-1) induced biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160: 618-623
7. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr (1985) Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol 121: 394-401
8. Bini A, Fenoglio JJ, Sobel J, Owen J, Feigl M, Kaplan KL (1987) Immunochemical characterization of fibrinogen, fibrin I and fibrin II in human thrombi and atherosclerotic lesions. Blood 69: 1038-1045
9. Bini A, Fenoglio JJ, Mesa Tejada R, Kudryk B, Kaplan KL (1989) Identification and distribution of fibrinogen, fibrin and fibrinogen degradation products in atherosclerosis. Arteriosclerosis 9: 109-121
10. Brox JH, Osterud B, Bjorklid E, Fenton JW (1984) Production and availability of thromboplastin in endothelial cells: The effects of thrombin, endotoxin and platelets. Br J Haematol 57: 239-246
11. Broze GJ, Leykam JE, Schwarts BD, Miletich JP (1985) Purification of human brain tissue factor. J Biol Chem 260: 10917-10920
12. Collen D, Juhan-Vague I (1988) Fibrinolysis and atherosclerosis. Semin Thromb Hemost 14: 180-183
13. Conkling PR, Greenberg CS, Weinberg KB (1988) Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocyte. Blood 72: 128-133
14. Contrino J, Hair GA, Schmeizl MA, Richles FR, Kreutzer DL (1994) In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes. Am J Pathol 145: 1315-1322
15. Dahlen GH, Guyton JR, Attar MA, Farmer JA, Kautz JA, Gotto AM Jr (1986) Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74: 758-765
16. Duguid JB (1948) Thrombosis as a factor in the pathogenesis of aortic atherosclerosis. J Path Bacteriolo 60: 57-61
17. Fei H, Berliner JA, Parhami F, Drake TA (1993) Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb 13: 1711-1717
18. Grainger DJ, Kirschenlohr HL, Metcalfe JC (1993) Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 260: 1655-1658
19. Guyton JR, Klemp KF (1993) Early extracellular and cellular lipid deposits in aorta of cholesterol-fed rabbits. Am J Pathol 141: 925-936
20. Hollander W, Paddock J, Colombo M (1979) Lipoproteins in human atherosclerotic vessels. Exp Mol pathol 30: 144-171
21. Hsu SM, Reine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29: 557-580
22. Ishida T, Tanaka K (1982) Effects of fibrin and fibrinogen degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis 44: 161-174
23. Kannel WB, D'Agostino RB, Belanger AJ (1987) Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham study. Am Heart J 113: 1006-1010
24. Koltringer P, Jurgens G (1985) A dominant role of lipoprotein(a) in the investigation and elevation parameters indicating the development of cervical atherosclerosis. Atherosclerosis 58: 187-198
25. Kostner GM, Avogara P, Cazzolato G, Marth E, Bittolobon G, Qunici GB (1981) Lipoprotein(a) and the risk for myocardial infarction. Atherosclerosis 38: 51-68
26. Kojima S, Harpel PC, Rifkin DB (1991) Lipoprotein(a) inhibits the generation of transforming growth factor β. J Cell Biol 113: 1439-1445
27. Köhler G, Milnstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497
28. Lesnik P, Rouis M, Skarlatos S, Kruth HS, Chapman MJ (1992) Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad USA 89: 10370-10374
29. Loscalzo J, Weinfeld M, Fless GM, Scanu AM (1990) Lipoprotein (a), fibrin binding and plasminogen activation. Arteriosclerosis 10: 240-245
30. McLean JW, Tomlinson JE, Kuang WJ (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330: 132-137
31. Meade TW, Imeson J, Strling Y (1987) Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1: 986-988
32. Mertens K, Bertina RM (1980) Pathways in the activation of human coagulation factor X. Biochem J 185: 647-658
33. Nemerson Y (1988) Tissue factor and hemostasis. Blood 71: 1-8
34. Ryan J, Brett J, Tijburg P, Bach RR, Kisiel W, Stern D (1992) Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood 80: 966-974
35. Sadoshima S, Tanaka K (1979) Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis. Atherosclerosis 34: 93-103
36. Schuff-Werner P, Claus G, Armstrong VW, Kostering K, Seidel D (1989) Enhanced procoagulatory activity (PCA) of human monocyte/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis 78 109-112
37. Shekhonin BV, Tararak EM, Samokhin GP, Mitkcvich OV, Mazurov AV, Vinogradov DV (1990) Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis. Atherosclerosis 82: 213-226
38. Shigematsu Y, Miyata T, Higashi S, Miki T, Sadler JE, Iwanaga S (1992) Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. J Biol Chem 267: 21329-21337
39. Silberberg JM, Gordon S, Zucker S (1990) Identification of tissue factor in two human pancreatic cancer cell lines. Cancer Res 49: 5443-5447
40. Smith EB (1986) Fibrinogen, fibrin and fibrin degradation productions in relation to atherosclerosis. Clin Haematol 15: 353-370
41. Smith EB (1993) Fibrinogen and atheroscslerosis. Wien Kln Wochenschr 105: 417-424
42. Stone MC, Thorpe JM (1985) Plasma fibrinogen- a major coronary risk factor. J R Coll Gen Pract 35: 565-569
43. Tanaka K, Sueishi K (1993) Biology of disease. The coagulation and fibrinolysis systems and atherosclerosis. Lab Invest 69: 5-18
44. 2+ mobilization and protein kinase C activation. J Clin Invest 91: 547-552
45. Tijburg P, Ryan J, Stern D, Wollitzky B, Rimon S, Rimon A, Handley D, Nawroth P, Sixma JJ, Groot PG (1991) Activation of the coagulation mechanism on tumor necrosis factor stimulated cultured endothelial cells and their extracellular matrix. J Biol Chem 266: 12067-12074
46. van Ginkel CJW, Zeijlemaker WP, Stricker LAM, Oh JIH, van Aken WG (1981) Enhancement of monocyte thromboplastin activity by antigenically simulated lymlphocytes: A link between immune reactivity and blood coagulation. Eur J Immunol. 11: 579-583
47. Wilcox JN, Smith KM, Schwartz SM, Gordon D (1989) Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86: 2839-2843
48. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G (1984) Fibrinogen as a risk factor stroke and myocardial infarction. New Engl J Med 311: 501-505